E0765 HCPCS Level II code: Fda approved nerve stimulator, for treatment of nausea and vomiting
E0765 is the HCPCS code for “Fda approved nerve stimulator, for treatment of nausea and vomiting” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
E0765Fda approved nerve stimulator, for treatment of nausea and vomiting
Short description: Nerve stimulator for tx n&v
HCPCS · United States
Medicare details
The indicators CMS publishes with E0765 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Non-covered by Medicare statute
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Other medical items or services
- BETOS category
- Undefined codes
- Coverage statute
- 1861(n)
- Added
- Jan 1, 2001
Where E0765 sits
- 1E codesDurable medical equipment
- 2Active code E0765Fda approved nerve stimulator, for treatment of nausea and vomiting
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code E0765 mean?
E0765 is the HCPCS code for “Fda approved nerve stimulator, for treatment of nausea and vomiting” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover E0765?
CMS lists E0765’s Medicare coverage as “Non-covered by Medicare statute” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside E0765
All E codesE0749Osteogenesis stimulator, electrical, surgically implantedE0755Electronic salivary reflex stimulator (intra-oral/non-invasive)E0760Osteogenesis stimulator, low intensity ultrasound, non-invasiveE0761Non-thermal pulsed high frequency radiowaves, high peak power electromagnetic energy treatment deviceE0762Transcutaneous electrical joint stimulation device system, includes all accessoriesE0764Functional neuromuscular stimulation, transcutaneous stimulation of sequential muscle groups of ambulation with computer control, used for walking by spinal cord injured, entire…E0766Electrical stimulation device used for cancer treatment, includes all accessories, any typeE0767Intrabuccal, systemic delivery of amplitude-modulated, radiofrequency electromagnetic field device, for cancer treatment, includes all accessoriesE0769Electrical stimulation or electromagnetic wound treatment device, not otherwise classifiedE0770Functional electrical stimulator, transcutaneous stimulation of nerve and/or muscle groups, any type, complete system, not otherwise specifiedE0776Iv poleE0779Ambulatory infusion pump, mechanical, reusable, for infusion 8 hours or greater